Independent pharmacist Benjamin Jolley expresses concern that tariffs meant to boost U.S. drug manufacturing may unintentionally hurt businesses and inflate prices for medications. He highlights a dual risk: while tariffs could protect against reliance on foreign nations for pharmaceuticals, they might trigger shortages and increased costs due to the U.S.'s dependence on ingredients from China and India. Industry experts overwhelmingly oppose such tariffs, indicating the potential for adverse effects on the healthcare system. Jolley's experience illustrates the stress on independent pharmacists navigating these challenging economic conditions.
I understand the rationale for tariffs. I'm not sure that we're gonna do it the right way. And I am definitely sure that it's going to raise the price that I pay my suppliers.
Slashing drug imports could trigger widespread shortages, experts said, because of America's dependence on Chinese- and Indian-made chemical ingredients, which form the critical building blocks of many medicines.
Big ships don't change course overnight.
Tariffs aimed at bringing drug production to the United States could instead drive companies out of business while raising prices and creating more of the drug shortages.
Collection
[
|
...
]